Ncardia
Charles Leach is an experienced professional in business development and management consultancy within the biotech and pharmaceutical sectors. Currently serving as the Business Development Manager for Ncardia, Charles focuses on fostering partnerships to enhance drug discovery through advanced iPSC technologies. Prior roles include Commercial Manager for GRAYCE, where Charles successfully expanded project scopes for FTSE100 clients, and Business Development Officer at OXGENE, driving innovation in drug discovery. Charles has also held consultancy positions at NES Fircroft, earning recognition for significant deals and performance. A dedicated content writer for the Science Entrepreneur Club, Charles leverages a strong educational background in Biomedical Sciences from Newcastle University.
Ncardia
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications. Explore our website to learn more www.ncardia.com.